Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti

PLoS Medicine

Volumn 4, Issue 5, 2007, Pages 0937-0947

  Schackman, Bruce R ^a   Neukermans, Christopher P ^a   Fontain, Sandy N Nerette ^b   Nolte, Claudine ^b   Joseph, Patrice ^b   Pape, Jean W ^b   Fitzgerald, Daniel W ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Adolescent Medicine   (Haïti)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONGENITAL SYPHILIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COURSE EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HAITI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MEDICAL DECISION MAKING; NEWBORN DEATH; OPPORTUNISTIC INFECTION; PREGNANT WOMAN; PRENATAL CARE; PRENATAL SCREENING; QUALITY OF LIFE; RURAL AREA; STILLBIRTH; SYPHILIS; URBAN AREA; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; ANALYTICAL EQUIPMENT; CHILD; DRUG COST; ECONOMICS; MASS SCREENING; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY COMPLICATION; TIME;

ADULT; CHILD; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; HAITI; HUMANS; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; REAGENT KITS, DIAGNOSTIC; SYPHILIS; SYPHILIS, CONGENITAL; TIME FACTORS;

EID: 34249752778     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040183     Document Type: Article

References (49)

1. Thorne C, Newell ML (2003) Mother-to-child transmission of HIV infection and its prevention. Curr HIV Res 1: 447-462.
2. Peeling RW, Mabey D, Fitzgerald DW, Watson-Jones D (2004) Avoiding HIV and dying of syphilis. Lancet 364: 1561-1563.
3. Walker DG, Walker GJ (2002) Forgotten but not gone: The continuing scourge of congenital syphilis. Lancet Infect Dis 2: 432-436.
4. Brosco JP, Mattingly M, Sanders LM (2006) Impact of specific medical interventions on reducing the prevalence of mental retardation. Arch Pediatr Adolesc Med 160: 302-309.
5. Steckelberg JM, McDonald TJ (1984) Otologic involvement in late syphilis. Laryngoscope 94: 753-757.
6. Hariprasad SM, Moon SJ, Allen RC, Wilhelmus KR (2002) Keratopathy from congenital syphilis. Cornea 21: 608-609.
7. Peeling RW, Ye H (2004) Diagnostic tools for preventing and managing maternal and congenital syphilis: An overview. Bull World Health Organ 82: 439-446.
8. Berman SM (2004) Maternal syphilis: Pathophysiology and treatment. Bull World Health Organ 82: 433-438.
9. The Sexually Transmitted Diseases Diagnostics Initiative (2003) Laboratory-based evaluation of rapid syphilis diagnostics: Results from 8 SDI sites. Geneva: UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Available: http://www.who.int/std_diagnostics/ publications/meetings/SDI_Report.pdf. Accessed 19 April 2007.
10. World Health Organization (2005) Coverage of maternity care: A listing of available information. Geneva: World Health Organization.
11. Centers for Disease Control and Prevention (1998) 1998 guidelines for treatment of sexually transmitted diseases. MMWR Recomm Rep 47: 1-118.
12. Murray CJ, Lopez AD, editors (1996) The global burden of disease: A Comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (Massachusetts): Harvard School of Public Health on behalf of the World Health Organization and the World Bank. 990 p.
13. Fox-Rushby JA, Hanson K (2001) Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 16: 326-331.
14. Terris-Prestholt F, Watson-Jones D, Mugeye K, Kumaranayake L, Ndeki L, et al. (2003) Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect 79: 375-381.
15. Fitzgerald DW, Behets FM, Lucet C, Roberfroid D (1998) Prevalence, burden, and control of syphilis in Haiti's rural Artibonite region. Int J Infect Dis 2: 127-131.
16. Montoya PJ, Lukehart SA, Brentlinger PE, Blanco AJ, Floriano F, et al. (2006) Comparison of the diagnostic accuracy of a rapid immunochromatographic test and the rapid plasma reagin test for antenatal syphilis screening in Mozambique. Bull World Health Organ 84: 97-104.
17. Ingraham NR Jr (1950) The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol Suppl (Stockh) 31: 60-87.
18. Myer L, Wilkinson D, Lombard C, Zuma K, Rotchford K, et al. (2003) Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: A randomised controlled trial. Sex Transm Infect 79: 208-213.
19. Watson-Jones D, Oliff M, Terris-Prestholt F, Changalucha J, Gumodoka B, et al. (2005) Antenatal syphilis screening in sub-Saharan Africa: Lessons learned from Tanzania. Trop Med Int Health 10: 934-943.
20. Petrus E, Levitan S, Paoliello A, Nicol R (1953) La campagne antipanique en Haiti. Bull World Health Organ 8: 261-271.
21. Samme GE (1956) Treponematosis eradication with special reference to yaws eradication in Haiti. Bull World Health Organ 15: 897-910.
22. Jean SS, Pape JW, Verdier RI, Reed GW, Hutto C, et al. (1999) The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J 18: 58-63.
23. Wendel GD Jr, Sheffield JS, Hollier LM, Hill JB, Ramsey PS, et al. (2002) Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis 35: S200-S209.
24. Desormeaux J, Behets FM, Adrien M, Coicou G, Dallabetta G, et al. (1996) Introduction of partner referral and treatment for control of sexually transmitted diseases in a poor Haitian community. Int J STD AIDS 7: 502-506.
25. World Health Organization (2005) The world health report 2005: Make every mother and child count. Geneva: World Health Organization. Available: http://www.who.int/whr/2005/whr2005_en.pdf. Accessed 19 April 2007.
26. Gold MR, Siegel JE, Russell LB, Weinstein MCeditors (1996) Cost-effectiveness in health and medicine. New York: Oxford University Press. 425 p.
27. Cantor SB (1994) Cost-effectiveness analysis, extended dominance, and ethics: A quantitative assessment. Med Decis Making 14: 259-265.
28. Nolte C (2004) HIV sero-prevalence among pregnant women in Haiti, 2003 [paper]. A Multicultural Caribbean United Against HIV/AIDS; 2004 5-6 March; Santo Domingo, Dominican Republic.
29. Institut Haitien de Statistique et d'Informatique (2003) 4ieme recensement général de la population et l'habitat. Porte-au-Prince: Institut Haitien de Statistique et d'Informatique. 37 p.
30. Mullick S, Broutet N, Htun Y, Temmerman M, Ndowa F (2004) Controlling congenital syphilis in the era of HIV/AIDS. Bull World Health Organ 82: 431-432.
31. Peck R, Fitzgerald DW, Liautaud B, Deschamps MM, Verdier RI, et al. (2003) The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: Evaluation of a 15-year experience in Haiti, 1985-2000. J Acquir Immune Defic Syndr 33: 470-475.
32. Rekart ML, Patrick DM, Chakraborty B, Maginley JJ, Jones HD, et al. (2003) Targeted mass treatment for syphilis with oral azithromycin. Lancet 361: 313-314.
33. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet 353: 525-535.
34. Korenromp EL, Van Vliet C, Grosskurth H, Gavyole A, Van der Ploeg CP, et al. (2000) Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS 14: 573-593.
35. World Bank (1993) World development report 1993: Investing in health. New York: Oxford University Press. 329 p.
36. World Health Organization (2001) Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/publications/2001/924154550X.pdf. Accessed 1 May 2007.
37. International Monetary Fund (2005) Haiti: Selected issues. Washington (D. C.): International Monetary Fund. IMF Country Report No. 05/205. Available: http://www.imf.org/external/pubs/ft/scr/2005/cr05205.pdf. Accessed 23 April 2007.
38. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, et al. (2000) Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 356: 113-121.
39. Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, et al. (1997) Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 350: 1805-1809.
40. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, et al. (1999) Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 354: 803-809.
41. Sweat MD, O'Reilly KR, Schmid GP, Denison J, de Zoysa I (2004) Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 18: 1661-1671.
42. US Department of State (2007) U.S. president's emergency plan for AIDS relief - Country profile: Haiti. Washington (D. C.): U.S. Department of State. http://www.state.gov/documents/organization/61622.pdf. Accessed 13 February 2007.
43. Schmid G (2004) Economic and programmatic aspects of congenital syphilis prevention. Bull World Health Organ 82: 402-409.
44. Fitzgerald DW, Behets F, Caliendo A, Roberfroid D, Lucet C, et al. (2000) Economic hardship and sexually transmitted diseases in Haiti's rural Artibonite Valley. Am J Trop Med Hyg 62: 496-501.
45. Moodley P, Sturm PD, Vanmali T, Wilkinson D, Connolly C, et al. (2003) Association between HIV-1 infection, the etiology of genital ulcer disease, and response to syndromic management. Sex Transm Dis 30: 241-245.
46. Gray RH, Wawer MJ, Sewankambo NK, Serwadda D, Li C, et al. (1999) Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. AIDS 13: 2113-2123.
47. Htun Y, Morse SA, Dangor Y, Fehler G, Radebe F, et al. (1998) Comparison of clinically directed, disease specific, and syndromic protocols for the management of genital ulcer disease in Lesotho. Sex Transm Infect 74: S23-S28.
48. Hoyo C, Hoffman I, Moser BK, Hobbs MM, Kazembe P, et al. (2005) Improving the accuracy of syndromic diagnosis of genital ulcer disease in Malawi. Sex Transm Dis 32: 231-237.
49. Levin CE, Steele M, Atherly D, Garcia SG, Tinajeros F, et al. (2007) Analysis of the operational costs of using rapid syphilis tests for the detection of maternal syphilis in Bolivia and Mozambique. Sex Transm Dis. E-pub ahead of print.